NOCIL Ltd
NOCIL Ltd., incorporated in 1961, manufactures rubber chemicals which are used by the tyre industry and other rubber processing industries.[1] It is a part of Arvind Mafatlal Group and is the Largest Rubber Chemicals Manufacturer in India.
- Market Cap ₹ 4,756 Cr.
- Current Price ₹ 285
- High / Low ₹ 336 / 210
- Stock P/E 38.0
- Book Value ₹ 101
- Dividend Yield 1.05 %
- ROCE 9.72 %
- ROE 7.18 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 33.4%
Cons
- Stock is trading at 2.82 times its book value
- Promoter holding is low: 33.8%
- Company has a low return on equity of 9.88% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
488 | 596 | 719 | 715 | 742 | 964 | 1,043 | 846 | 925 | 1,571 | 1,617 | 1,445 | 1,420 | |
469 | 535 | 606 | 577 | 584 | 698 | 752 | 670 | 798 | 1,287 | 1,367 | 1,254 | 1,245 | |
Operating Profit | 20 | 61 | 113 | 139 | 159 | 266 | 291 | 177 | 127 | 284 | 249 | 190 | 175 |
OPM % | 4% | 10% | 16% | 19% | 21% | 28% | 28% | 21% | 14% | 18% | 15% | 13% | 12% |
36 | 9 | 3 | 3 | 8 | 11 | 10 | 10 | 14 | 3 | 7 | 40 | 46 | |
Interest | 4 | 17 | 17 | 9 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Depreciation | 8 | 18 | 14 | 14 | 19 | 23 | 23 | 32 | 36 | 47 | 54 | 51 | 52 |
Profit before tax | 44 | 35 | 86 | 118 | 146 | 253 | 277 | 152 | 104 | 240 | 201 | 177 | 167 |
Tax % | 4% | 32% | 34% | 34% | 34% | 33% | 33% | 14% | 17% | 27% | 26% | 26% | |
42 | 24 | 57 | 78 | 97 | 169 | 184 | 131 | 86 | 176 | 149 | 131 | 125 | |
EPS in Rs | 2.64 | 1.47 | 3.53 | 4.83 | 5.92 | 10.25 | 11.13 | 7.91 | 5.20 | 10.56 | 8.92 | 7.88 | 7.50 |
Dividend Payout % | 23% | 41% | 28% | 25% | 30% | 24% | 22% | 32% | 38% | 28% | 34% | 38% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 7% |
3 Years: | 16% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | 17% |
5 Years: | -9% |
3 Years: | 11% |
TTM: | 7% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 27% |
3 Years: | 1% |
1 Year: | 25% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 10% |
3 Years: | 10% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 161 | 161 | 161 | 161 | 164 | 164 | 165 | 166 | 166 | 167 | 167 | 167 |
Reserves | 203 | 216 | 253 | 307 | 741 | 873 | 988 | 1,010 | 1,107 | 1,267 | 1,374 | 1,518 |
147 | 152 | 147 | 26 | 15 | 5 | 0 | 0 | 6 | 6 | 10 | 13 | |
151 | 208 | 196 | 185 | 228 | 273 | 275 | 252 | 320 | 377 | 291 | 298 | |
Total Liabilities | 662 | 736 | 757 | 679 | 1,148 | 1,316 | 1,428 | 1,428 | 1,599 | 1,816 | 1,841 | 1,996 |
301 | 302 | 293 | 290 | 518 | 503 | 629 | 769 | 892 | 884 | 863 | 846 | |
CWIP | 3 | 3 | 3 | 6 | 3 | 39 | 131 | 156 | 14 | 8 | 8 | 16 |
Investments | 47 | 47 | 47 | 47 | 201 | 302 | 148 | 72 | 82 | 67 | 231 | 407 |
310 | 384 | 413 | 335 | 426 | 472 | 520 | 430 | 611 | 857 | 739 | 727 | |
Total Assets | 662 | 736 | 757 | 679 | 1,148 | 1,316 | 1,428 | 1,428 | 1,599 | 1,816 | 1,841 | 1,996 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 44 | 27 | 165 | 140 | 98 | 164 | 177 | 90 | -32 | 278 | 196 | |
-77 | -18 | -5 | -12 | -9 | -138 | -102 | -104 | -55 | 33 | -214 | -72 | |
52 | -23 | -33 | -151 | -31 | -42 | -50 | -101 | 0 | -34 | -54 | -55 | |
Net Cash Flow | -24 | 3 | -10 | 2 | 101 | -81 | 12 | -28 | 36 | -33 | 10 | 69 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 83 | 90 | 85 | 77 | 82 | 92 | 81 | 88 | 122 | 104 | 78 | 86 |
Inventory Days | 133 | 167 | 176 | 134 | 116 | 128 | 133 | 128 | 119 | 141 | 117 | 100 |
Days Payable | 83 | 130 | 84 | 75 | 82 | 94 | 77 | 84 | 124 | 92 | 53 | 53 |
Cash Conversion Cycle | 134 | 128 | 177 | 136 | 116 | 126 | 137 | 132 | 118 | 153 | 142 | 133 |
Working Capital Days | 88 | 89 | 106 | 85 | 86 | 94 | 99 | 104 | 114 | 128 | 108 | 110 |
ROCE % | 6% | 10% | 19% | 24% | 21% | 26% | 25% | 13% | 8% | 18% | 13% | 10% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 7h
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
21 Aug - Pursuant to the Company''s ""Employee Stock Option Scheme- 2007 as amended, the Nomination and Remuneration Committee has allotted 2,17,850 Equity Shares of the face value …
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 20 Aug
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 19 Aug
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 9 Aug
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
May 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020TranscriptNotesPPT
-
Jun 2020Transcript PPT
-
Jan 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Jul 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Jul 2018TranscriptNotesPPT
-
May 2018Transcript PPT
-
Feb 2018TranscriptNotesPPT
-
Oct 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017Transcript PPT
-
Feb 2017TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
-
Dec 2015TranscriptNotesPPT
Products
The co’s product portfolio mainly includes Rubber Chemicals which further includes Antidegradants or Antioxidants, Accelerators and products for non-automobile industry like products F, ZDC, ZDBC, ZMBT, SDBC, ZBZDC, DHTS.
It also manufactures pre-vulcanisation inhibitors and post-vulcanisation stabilizers. [1][2] The company has 20+ products varieties of rubber chemicals.[3]